Attached files
| file | filename |
|---|---|
| S-1 - REGISTRATION STATEMENT - VistaGen Therapeutics, Inc. | vtgns1_oct2017000.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
hereby consent to the use, in the Prospectus constituting a part of
this Registration Statement on Form S-1, of our report dated June
29, 2017 (which report expresses an unqualified opinion and
includes an explanatory paragraph expressing substantial doubt
about the Company’s ability to continue as a going concern)
relating to the consolidated financial statements of VistaGen
Therapeutics, Inc., which is contained
in Part II of the Registration Statement.
We also
consent to the reference to us under the caption “Experts” in
the Prospectus.
/s/ OUM
& CO. LLP
San
Francisco, California
October
18, 2017